Every major player in your health system gets a direct line to the industry’s most-needed insights and
the support to take action. Learn more.
Our research programs are role-specific to provide the exact insights and resources
that will make your job easier. We offer research for:
Create an account
News, resources, and analysis from the Cardiovascular Roundtable
by Emily Snow December 5, 2018
During the first week of November, CMS released its annual finalized regulations for payments to hospital outpatient departments (HOPDs), paid under the Hospital Outpatient Prospective Payment System (HOPPS), and physicians, paid under the Medicare Physician Fee Schedule (MPFS). Our key takeaway from the two rules this year: CMS is taking clear measures to control outpatient spending.
Read more »
by Jordan Sanford November 21, 2018
Experts believe that we are on the cusp of exponential growth in the speed at which we can process information. This growth is fueled in part by advances in artificial intelligence (AI), which has the potential to disrupt the health care industry as we know it. According to Advisory Board research, the market size for AI technologies is expected to grow from $600 million in 2014 to $6.6 billion in 2021—and 50% of hospitals are forecasted to use such technologies in the next five years.
October 24, 2018
Since TAVR first hit the U.S. market, structural heart programs have made vast improvements in increasing efficiency of the program and the procedure. These efforts have not only increased outcomes and experience for patients, but also improved fiscal sustainability of these resource-intensive programs.
by Aaron Mauck and Daniel Roza October 12, 2018
On October 18, 2018, the United Network for Organ Sharing (UNOS) will implement extensive changes to its adult heart allocation policy, which may have implications for your transplant-eligible patients.
by Megan Tooley and Emily Snow September 26, 2018
As usual, this summer brought new CMS proposals for outpatient and physician payments, which if finalized would go into effect for the 2019 calendar year. While this year's proposed updates were not as monumental as some in recent years, there are still some significant changes that will impact cardiovascular service lines.
by Megan Tooley and Dhananjai Seth September 12, 2018
Optimizing management of heart failure (HF) patients has been a priority for cardiovascular programs for years, and CV leaders are continuing to evaluate new opportunities to better treat this growing patient population. In fact, the American Heart Association expects the prevalence of heart failure to grow by 46%, to 8.5 million individuals, by 2030.
Megan Tooley August 29, 2018
Editor's note: This story was updated on November 6, 2018.
A few weeks ago, four CV societies jointly released a new expert consensus document on operator and institutional requirements for transcatheter aortic valve replacement (TAVR)—a statement that existing and aspiring TAVR programs have been anxiously awaiting for nearly a year.
Megan Tooley , Aaron Mauck August 1, 2018
Cardiovascular programs have spent decades developing strategies to optimize the care for cardiac conditions. Vascular conditions, on the other hand, are often approached as an afterthought.
You must be logged in to comment